Anti-Migraine Drugs Market
1 Introduction to Research & Analysis Reports
1.1 Anti-Migraine Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Migraine Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Migraine Drugs Overall Market Size
2.1 Global Anti-Migraine Drugs Market Size: 2021 VS 2028
2.2 Global Anti-Migraine Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-Migraine Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Anti-Migraine Drugs Players in Global Market
3.2 Top Global Anti-Migraine Drugs Companies Ranked by Revenue
3.3 Global Anti-Migraine Drugs Revenue by Companies
3.4 Global Anti-Migraine Drugs Sales by Companies
3.5 Global Anti-Migraine Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-Migraine Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-Migraine Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Migraine Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-Migraine Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Migraine Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Migraine Drugs Market Size Markets, 2021 & 2028
4.1.2 Triptans
4.1.3 Ergots
4.1.4 Others
4.2 By Type - Global Anti-Migraine Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Migraine Drugs Revenue, 2017-2022
4.2.2 By Type - Global Anti-Migraine Drugs Revenue, 2023-2028
4.2.3 By Type - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Anti-Migraine Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-Migraine Drugs Sales, 2017-2022
4.3.2 By Type - Global Anti-Migraine Drugs Sales, 2023-2028
4.3.3 By Type - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Anti-Migraine Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Anti-Migraine Drugs Market Size, 2021 & 2028
5.1.2 Women
5.1.3 Men
5.2 By Application - Global Anti-Migraine Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Migraine Drugs Revenue, 2017-2022
5.2.2 By Application - Global Anti-Migraine Drugs Revenue, 2023-2028
5.2.3 By Application - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Anti-Migraine Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-Migraine Drugs Sales, 2017-2022
5.3.2 By Application - Global Anti-Migraine Drugs Sales, 2023-2028
5.3.3 By Application - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Anti-Migraine Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Anti-Migraine Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anti-Migraine Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Migraine Drugs Revenue, 2017-2022
6.2.2 By Region - Global Anti-Migraine Drugs Revenue, 2023-2028
6.2.3 By Region - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Anti-Migraine Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-Migraine Drugs Sales, 2017-2022
6.3.2 By Region - Global Anti-Migraine Drugs Sales, 2023-2028
6.3.3 By Region - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Anti-Migraine Drugs Revenue, 2017-2028
6.4.2 By Country - North America Anti-Migraine Drugs Sales, 2017-2028
6.4.3 US Anti-Migraine Drugs Market Size, 2017-2028
6.4.4 Canada Anti-Migraine Drugs Market Size, 2017-2028
6.4.5 Mexico Anti-Migraine Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Anti-Migraine Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Anti-Migraine Drugs Sales, 2017-2028
6.5.3 Germany Anti-Migraine Drugs Market Size, 2017-2028
6.5.4 France Anti-Migraine Drugs Market Size, 2017-2028
6.5.5 U.K. Anti-Migraine Drugs Market Size, 2017-2028
6.5.6 Italy Anti-Migraine Drugs Market Size, 2017-2028
6.5.7 Russia Anti-Migraine Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Anti-Migraine Drugs Market Size, 2017-2028
6.5.9 Benelux Anti-Migraine Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Anti-Migraine Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Anti-Migraine Drugs Sales, 2017-2028
6.6.3 China Anti-Migraine Drugs Market Size, 2017-2028
6.6.4 Japan Anti-Migraine Drugs Market Size, 2017-2028
6.6.5 South Korea Anti-Migraine Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Anti-Migraine Drugs Market Size, 2017-2028
6.6.7 India Anti-Migraine Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Anti-Migraine Drugs Revenue, 2017-2028
6.7.2 By Country - South America Anti-Migraine Drugs Sales, 2017-2028
6.7.3 Brazil Anti-Migraine Drugs Market Size, 2017-2028
6.7.4 Argentina Anti-Migraine Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Migraine Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Anti-Migraine Drugs Sales, 2017-2028
6.8.3 Turkey Anti-Migraine Drugs Market Size, 2017-2028
6.8.4 Israel Anti-Migraine Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Anti-Migraine Drugs Market Size, 2017-2028
6.8.6 UAE Anti-Migraine Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Anti-Migraine Drugs Major Product Offerings
7.1.4 Eli Lilly Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly Key News
7.2 Abbott
7.2.1 Abbott Corporate Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Anti-Migraine Drugs Major Product Offerings
7.2.4 Abbott Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Abbott Key News
7.3 Eisai
7.3.1 Eisai Corporate Summary
7.3.2 Eisai Business Overview
7.3.3 Eisai Anti-Migraine Drugs Major Product Offerings
7.3.4 Eisai Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Eisai Key News
7.4 Allergan
7.4.1 Allergan Corporate Summary
7.4.2 Allergan Business Overview
7.4.3 Allergan Anti-Migraine Drugs Major Product Offerings
7.4.4 Allergan Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Allergan Key News
7.5 Endo
7.5.1 Endo Corporate Summary
7.5.2 Endo Business Overview
7.5.3 Endo Anti-Migraine Drugs Major Product Offerings
7.5.4 Endo Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Endo Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Anti-Migraine Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.6.5 GlaxoSmithKline Key News
7.7 Impax Laboratories
7.7.1 Impax Laboratories Corporate Summary
7.7.2 Impax Laboratories Business Overview
7.7.3 Impax Laboratories Anti-Migraine Drugs Major Product Offerings
7.7.4 Impax Laboratories Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Impax Laboratories Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Anti-Migraine Drugs Major Product Offerings
7.8.4 Pfizer Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Key News
7.9 AstraZeneca
7.9.1 AstraZeneca Corporate Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Anti-Migraine Drugs Major Product Offerings
7.9.4 AstraZeneca Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.9.5 AstraZeneca Key News
7.10 Bayer
7.10.1 Bayer Corporate Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Anti-Migraine Drugs Major Product Offerings
7.10.4 Bayer Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Bayer Key News
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Corporate Summary
7.11.2 Johnson & Johnson Anti-Migraine Drugs Business Overview
7.11.3 Johnson & Johnson Anti-Migraine Drugs Major Product Offerings
7.11.4 Johnson & Johnson Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Johnson & Johnson Key News
7.12 Merck
7.12.1 Merck Corporate Summary
7.12.2 Merck Anti-Migraine Drugs Business Overview
7.12.3 Merck Anti-Migraine Drugs Major Product Offerings
7.12.4 Merck Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Merck Key News
7.13 Teva
7.13.1 Teva Corporate Summary
7.13.2 Teva Anti-Migraine Drugs Business Overview
7.13.3 Teva Anti-Migraine Drugs Major Product Offerings
7.13.4 Teva Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Teva Key News
7.14 Amgen
7.14.1 Amgen Corporate Summary
7.14.2 Amgen Business Overview
7.14.3 Amgen Anti-Migraine Drugs Major Product Offerings
7.14.4 Amgen Anti-Migraine Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Amgen Key News
8 Global Anti-Migraine Drugs Production Capacity, Analysis
8.1 Global Anti-Migraine Drugs Production Capacity, 2017-2028
8.2 Anti-Migraine Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Migraine Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Migraine Drugs Supply Chain Analysis
10.1 Anti-Migraine Drugs Industry Value Chain
10.2 Anti-Migraine Drugs Upstream Market
10.3 Anti-Migraine Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Migraine Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Anti-Migraine Drugs in Global Market
Table 2. Top Anti-Migraine Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Anti-Migraine Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Anti-Migraine Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Anti-Migraine Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Anti-Migraine Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Anti-Migraine Drugs Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Anti-Migraine Drugs Product Type
Table 9. List of Global Tier 1 Anti-Migraine Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Migraine Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Anti-Migraine Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Anti-Migraine Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Anti-Migraine Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Anti-Migraine Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Anti-Migraine Drugs Sales (K Units), 2023-2028
Table 16. By Application ? Global Anti-Migraine Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Anti-Migraine Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Anti-Migraine Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Anti-Migraine Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Anti-Migraine Drugs Sales (K Units), 2023-2028
Table 21. By Region ? Global Anti-Migraine Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Anti-Migraine Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Anti-Migraine Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Anti-Migraine Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Anti-Migraine Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Anti-Migraine Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Anti-Migraine Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Anti-Migraine Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Anti-Migraine Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Anti-Migraine Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Anti-Migraine Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Anti-Migraine Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Anti-Migraine Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Anti-Migraine Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Anti-Migraine Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Anti-Migraine Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Anti-Migraine Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Anti-Migraine Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Anti-Migraine Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Anti-Migraine Drugs Sales, (K Units), 2023-2028
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Anti-Migraine Drugs Product Offerings
Table 48. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Abbott Corporate Summary
Table 50. Abbott Anti-Migraine Drugs Product Offerings
Table 51. Abbott Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Eisai Corporate Summary
Table 53. Eisai Anti-Migraine Drugs Product Offerings
Table 54. Eisai Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Allergan Corporate Summary
Table 56. Allergan Anti-Migraine Drugs Product Offerings
Table 57. Allergan Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Endo Corporate Summary
Table 59. Endo Anti-Migraine Drugs Product Offerings
Table 60. Endo Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. GlaxoSmithKline Corporate Summary
Table 62. GlaxoSmithKline Anti-Migraine Drugs Product Offerings
Table 63. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Impax Laboratories Corporate Summary
Table 65. Impax Laboratories Anti-Migraine Drugs Product Offerings
Table 66. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Pfizer Corporate Summary
Table 68. Pfizer Anti-Migraine Drugs Product Offerings
Table 69. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. AstraZeneca Corporate Summary
Table 71. AstraZeneca Anti-Migraine Drugs Product Offerings
Table 72. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Bayer Corporate Summary
Table 74. Bayer Anti-Migraine Drugs Product Offerings
Table 75. Bayer Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Johnson & Johnson Corporate Summary
Table 77. Johnson & Johnson Anti-Migraine Drugs Product Offerings
Table 78. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Merck Corporate Summary
Table 80. Merck Anti-Migraine Drugs Product Offerings
Table 81. Merck Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Teva Corporate Summary
Table 83. Teva Anti-Migraine Drugs Product Offerings
Table 84. Teva Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Amgen Corporate Summary
Table 86. Amgen Anti-Migraine Drugs Product Offerings
Table 87. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Anti-Migraine Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Anti-Migraine Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Anti-Migraine Drugs Production by Region, 2017-2022 (K Units)
Table 91. Global Anti-Migraine Drugs Production by Region, 2023-2028 (K Units)
Table 92. Anti-Migraine Drugs Market Opportunities & Trends in Global Market
Table 93. Anti-Migraine Drugs Market Drivers in Global Market
Table 94. Anti-Migraine Drugs Market Restraints in Global Market
Table 95. Anti-Migraine Drugs Raw Materials
Table 96. Anti-Migraine Drugs Raw Materials Suppliers in Global Market
Table 97. Typical Anti-Migraine Drugs Downstream
Table 98. Anti-Migraine Drugs Downstream Clients in Global Market
Table 99. Anti-Migraine Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Migraine Drugs Segment by Type
Figure 2. Anti-Migraine Drugs Segment by Application
Figure 3. Global Anti-Migraine Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-Migraine Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-Migraine Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Anti-Migraine Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Migraine Drugs Revenue in 2021
Figure 9. By Type - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Anti-Migraine Drugs Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Anti-Migraine Drugs Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 19. US Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 24. Germany Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 33. China Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Anti-Migraine Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Anti-Migraine Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Anti-Migraine Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Anti-Migraine Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Anti-Migraine Drugs by Region, 2021 VS 2028
Figure 50. Anti-Migraine Drugs Industry Value Chain
Figure 51. Marketing Channels